A Leader in the canadian cannabis industry.

Since 2013, CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories: the adult use market, over-the-counter, natural healthcare products, pet care, and beauty.

For Investors

NYSE Ticker: CTST

TSE Ticker: TRST

Press release

CannTrust Provides Default Status Report

VAUGHAN, ON, March 26, 2020 /CNW/ – CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST, NYSE: CTST) today provided a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 –...

CannTrust Provides Update Regarding Health Canada Remediation

COVID-19 Could Further Delay Efforts to Reinstate Cannabis Licenses VAUGHAN, ON, March 23, 2020 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST, NYSE: CTST) announced today that it received a notification from Health Canada as a result of...

CannTrust Provides Update Regarding TSX Listing

TSX Extends CannTrust's Disclosure Requirements Deadline VAUGHAN, ON, March 18, 2020 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST, NYSE: CTST) announced today that the Toronto Stock Exchange ("TSX") has extended the Company's current March...

CannTrust Provides Default Status Report

VAUGHAN, ON, March 12, 2020 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST, NYSE: CTST) today provided a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 –...

CannTrust Receives Continued Listing Notice from the NYSE

VAUGHAN, ON, Feb. 28, 2020 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST, NYSE: CTST) announced today that on February 27, 2020 the Company received written notification from the New York Stock Exchange (the "NYSE") that CannTrust is no...

CannTrust Provides Default Status Report

VAUGHAN, ON, Feb. 27, 2020 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company",TSX: TRST, NYSE: CTST) today provided a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 –...

CANNTRUST

Since 2013 CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories.

SUBSCRIBE TO INVESTOR NEWSLETTER

Subscribe Now

FOLLOW US

© CannTrust 2019

Terms & Conditions | Accessibility

Pin It on Pinterest